Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04268498
Title A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
Acronym ADVANCE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Miami Florida 33136 United States Details
Moffitt Cancer Center Tampa Florida 33612-9497 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Stony Brook University Stony Brook New York 11794 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institue Salt Lake City Utah 84113 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field